The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Feasibility of circulating tumor DNA (ctDNA) to guide organ preservation in patients with node-negative rectal cancer undergoing neoadjuvant chemotherapy, excision, and observation in the phase II CCTG CO.28 trial.
 
Jonathan M. Loree
Consulting or Advisory Role - AMGEN; Bayer; Eisai; Ipsen; Novartis; Pfizer; Taiho Pharmaceutical
Research Funding - Amgen (Inst); Ipsen (Inst)
 
Russell Madison
Employment - Foundation Medicine
Stock and Other Ownership Interests - Roche
 
Christopher J. O'Callaghan
No Relationships to Disclose
 
Carl J Brown
Honoraria - Ethicon/Johnson & Johnson
Other Relationship - Medtronic (Inst)
 
Dongsheng Tu
No Relationships to Disclose
 
Derek J. Jonker
No Relationships to Disclose
 
Max Sherry
No Relationships to Disclose
 
Alexander D. Fine
Employment - Foundation Medicine
Stock and Other Ownership Interests - Roche
 
Yanmei Huang
Employment - Foundation Medicine
Stock and Other Ownership Interests - Roche
Patents, Royalties, Other Intellectual Property - Foundation Medicine
 
William Camara
Employment - Foundation Medicine
Stock and Other Ownership Interests - Roche
 
Prapti Pokharel
Employment - Foundation Medicine
Stock and Other Ownership Interests - Roche
 
Alexey Aleshin
Employment - Natera; Natera
Leadership - Natera
Stock and Other Ownership Interests - Natera
Consulting or Advisory Role - Mission Bio; Mission Bio
Travel, Accommodations, Expenses - Natera
 
Geoffrey R. Oxnard
Employment - Foundation Medicine
Stock and Other Ownership Interests - Roche
 
Hagen Fritz Kennecke
Honoraria - Natera; Novartis; Tersera
Consulting or Advisory Role - Tersera
Speakers' Bureau - Natera
Research Funding - Exelixis (Inst); Novartis (Inst); Taiho Pharmaceutical (Inst)